首页> 外文期刊>Cellular Oncology: Analytical Cellular Pathology >PRIMA-1METInhibits Growth of Mouse Tumors Carrying Mutant p53
【24h】

PRIMA-1METInhibits Growth of Mouse Tumors Carrying Mutant p53

机译:PRIMA-1MET抑制携带突变型p53的小鼠肿瘤的生长

获取原文
           

摘要

Reactivation of the tumor suppressor activity to mutant p53 should trigger massive apoptosis and eliminate tumors. The low molecular weight compounds PRIMA-1 and the structural analog PRIMA-1METreactivate human mutant p53in vitroand suppress growth of human tumor xenografts in SCID mice. However, little is known about their effect on mouse mutant p53 in mouse tumor cells. We have examined the effect of PRIMA-1METon mouse sarcomas, mammary carcinomas and chemically induced fibrosarcomas. PRIMA-1METshowed potent growth suppression in mutant p53-carrying mouse tumorsin vitroand a significant anti-tumor effect in syngeneic micein vivo. These results demonstrate that PRIMA-1METtargets mouse tumors carrying mutant p53 and provide strong support for the anti-tumor efficiency of PRIMA-1METin vivo.
机译:重新激活突变体p53的抑癌活性应触发大量凋亡并消除肿瘤。低分子量化合物PRIMA-1和结构类似物PRIMA-1MET可以在体外重新激活人突变体p53,并抑制SCID小鼠中人肿瘤异种移植物的生长。然而,关于它们对小鼠肿瘤细胞中的小鼠突变体p53的作用所知甚少。我们已经检查了PRIMA-1MET对小鼠肉瘤,乳癌和化学诱导的纤维肉瘤的作用。 PRIMA-1MET在携带突变型p53的小鼠肿瘤中显示出有效的生长抑制作用,并且在同基因小鼠中显示出显着的抗肿瘤作用。这些结果证明PRIMA-1MET靶向携带突变体p53的小鼠肿瘤,并为体内PRIMA-1MET的抗肿瘤效率提供了有力的支持。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号